{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:30:54Z","timestamp":1786991454704,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000143","name":"Alzheimer Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008914","name":"Ontario Brain Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012498","name":"Alzheimer Society Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013873","name":"Government of Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015070","name":"Department of Psychiatry, University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jamda.2021.12.043","type":"journal-article","created":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T23:45:28Z","timestamp":1644191128000},"page":"1066-1072.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Potential Unintended Consequences of Antipsychotic Reduction in Ontario Nursing Homes"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4318-7373","authenticated-orcid":false,"given":"Daniel A.","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Maclagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Iaboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Rosella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen J.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Campitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila","family":"Pequeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kirkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Bronskill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2021.12.043_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2105\/AJPH.70.5.485","article-title":"A\u00a0study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse","volume":"70","author":"Ray","year":"1980","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jamda.2021.12.043_bib2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2318-13-52","article-title":"Potentially inappropriate medications used by the elderly: prevalence and risk factors in Brazilian care homes","volume":"13","author":"Vieira de Lima","year":"2013","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jamda.2021.12.043_bib3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s11096-016-0318-1","article-title":"Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand","volume":"38","author":"Tordoff","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jamda.2021.12.043_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrneurol.2009.39","article-title":"Management of agitation and aggression associated with Alzheimer disease","volume":"5","author":"Ballard","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jamda.2021.12.043_bib5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS beers criteria(R) for potentially inappropriate medication use in older adults","volume":"67","year":"2019","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2021.12.043_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2021.12.043_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1533317510390351","article-title":"Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence","volume":"26","author":"Mittal","year":"2011","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.jamda.2021.12.043_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/pds.4385","article-title":"Relevance of frailty to mortality associated with the use of antipsychotics among community-residing older adults with impaired cognition","volume":"27","author":"Maxwell","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jamda.2021.12.043_bib11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/M19-0993","article-title":"Comparative efficacy of interventions for aggressive and agitated behaviors in dementia: a systematic review and network meta-analysis","volume":"171","author":"Watt","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2021.12.043_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3122\/jabfm.2018.01.170230","article-title":"Primary care physician perspectives about antipsychotics and other medications for symptoms of dementia","volume":"31","author":"Kerns","year":"2018","journal-title":"J\u00a0Am Board Fam Med"},{"key":"10.1016\/j.jamda.2021.12.043_bib13","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jamda.2020.05.039","article-title":"Trends in antipsychotic and mood stabilizer prescribing in long-term care in the U.S.: 2011-2014","volume":"21","author":"Gerlach","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2021.12.043_bib14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jamainternmed.2018.0379","article-title":"Association of the Centers for Medicare and Medicaid Services' national partnership to improve dementia care with the use of antipsychotics and other psychotropics in long-term care in the United States from 2009 to 2014","volume":"178","author":"Maust","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2021.12.043_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/13607863.2016.1277974","article-title":"Perceptions vs. evidence: therapeutic substitutes for antipsychotics in patients with dementia in long-term care","volume":"22","author":"Olivieri-Mui","year":"2018","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.jamda.2021.12.043_bib16","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1111\/jgs.15519","article-title":"Low-dose trazodone, benzodiazepines, and fall-related injuries in nursing homes: a matched-cohort study","volume":"66","author":"Bronskill","year":"2018","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2021.12.043_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12877-020-01607-7","article-title":"Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: a systematic review and network meta-analysis","volume":"20","author":"Watt","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jamda.2021.12.043_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40501-017-0104-2","article-title":"Antipsychotics, antidepressants, anticonvulsants, melatonin, and benzodiazepines for behavioral and psychological symptoms of dementia: a systematic review of meta-analyses","volume":"4","author":"Tampi","year":"2017","journal-title":"Curr Treatment Opt Psychiatry"},{"key":"10.1016\/j.jamda.2021.12.043_bib19","first-page":"83","article-title":"Physician code creep: evidence in medicaid and state employee health insurance billing","volume":"28","author":"Seiber","year":"2007","journal-title":"Health Care Financ Rev"},{"key":"10.1016\/j.jamda.2021.12.043_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10754-016-9201-9","article-title":"Economic incentives and diagnostic coding in a public health care system","volume":"17","author":"Anthun","year":"2017","journal-title":"Int J Health Econ Manag"},{"key":"10.1016\/j.jamda.2021.12.043_bib21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hec.2959","article-title":"Medicare skilled nursing facility reimbursement and upcoding","volume":"23","author":"Bowblis","year":"2014","journal-title":"Health Econ"},{"issue":"suppl 2","key":"10.1016\/j.jamda.2021.12.043_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/hec.3541","article-title":"Do public hospitals respond to changes in DRG price regulation? The case of birth deliveries in the Italian NHS","volume":"26","author":"Di Giacomo","year":"2017","journal-title":"Health Econ"},{"key":"10.1016\/j.jamda.2021.12.043_bib23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1080\/13607863.2019.1571015","article-title":"Nursing homes underreport antipsychotic prescribing","volume":"24","author":"Briesacher","year":"2020","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.jamda.2021.12.043_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/07317115.2017.1395378","article-title":"Increased reporting of exclusionary diagnoses inflate apparent reductions in long-stay antipsychotic prescribing","volume":"42","author":"Winter","year":"2019","journal-title":"Clin Gerontol"},{"key":"10.1016\/j.jamda.2021.12.043_bib25","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1111\/jgs.17464","article-title":"Disproportionate increases in schizophrenia diagnoses among Black nursing home residents with ADRD","volume":"69","author":"Fashaw-Walters","year":"2021","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2021.12.043_bib26","author":"Thomas"},{"key":"10.1016\/j.jamda.2021.12.043_bib27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jagp.2015.07.001","article-title":"Trends in psychotropic dispensing among older adults with dementia living in long-term care facilities: 2004-2013","volume":"23","author":"Vasudev","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2021.12.043_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40266-016-0380-3","article-title":"Changing pattern of sedative use in older adults: a population-based cohort study","volume":"33","author":"Iaboni","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2021.12.043_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/2045125317743651","article-title":"Benzodiazepine prescription in Ontario residents aged 65 and over: a population-based study from 1998 to 2013","volume":"8","author":"Davies","year":"2018","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.jamda.2021.12.043_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/070674371305800708","article-title":"Trends in psychotropic use in Saskatchewan from 1983 to 2007","volume":"58","author":"Meng","year":"2013","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.jamda.2021.12.043_bib31","doi-asserted-by":"crossref","first-page":"E582","DOI":"10.9778\/cmajo.20190052","article-title":"Time trends in opioid prescribing among Ontario long-term care residents: a repeated cross-sectional study","volume":"7","author":"Iaboni","year":"2019","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jamda.2021.12.043_bib32","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/jgs.15013","article-title":"The variation of statin use among nursing home residents and physicians: a cross-sectional analysis","volume":"65","author":"Campitelli","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2021.12.043_bib33","doi-asserted-by":"crossref","first-page":"E270","DOI":"10.1503\/cmaj.201473","article-title":"Trends in prevalence of chronic disease and multimorbidity in Ontario, Canada","volume":"193","author":"Steffler","year":"2021","journal-title":"CMAJ"},{"key":"10.1016\/j.jamda.2021.12.043_bib34","doi-asserted-by":"crossref","first-page":"e037485","DOI":"10.1136\/bmjopen-2020-037485","article-title":"Trajectories of health system use and survival for community-dwelling persons with dementia: a cohort study","volume":"10","author":"Bronskill","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2021.12.043_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/bmjqs-2018-007840","article-title":"Public reporting of antipsychotic prescribing in nursing homes: population-based interrupted time series analyses","volume":"28","author":"Ivers","year":"2019","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.jamda.2021.12.043_bib36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","article-title":"The prevalence of neuropsychiatric symptoms in alzheimer's disease: systematic review and meta-analysis","volume":"190","author":"Zhao","year":"2016","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.jamda.2021.12.043_bib37","doi-asserted-by":"crossref","first-page":"M174","DOI":"10.1093\/geronj\/49.4.M174","article-title":"MDS cognitive performance scale","volume":"49","author":"Morris","year":"1994","journal-title":"J\u00a0Gerontol"},{"key":"10.1016\/j.jamda.2021.12.043_bib38","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1111\/j.1532-5415.2008.02048.x","article-title":"The aggressive behavior scale: a new scale to measure aggression based on the minimum data set","volume":"56","author":"Perlman","year":"2008","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2021.12.043_bib39","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun StatSimul Comput"},{"key":"10.1016\/j.jamda.2021.12.043_bib40","series-title":"Use of Antipsychotics Soaring at Ontario Nursing Homes Toronto","author":"Bruser","year":"2014"},{"key":"10.1016\/j.jamda.2021.12.043_bib41","series-title":"Database of Antipsychotic Drugs in Nursing Homes Toronto","author":"Bruser","year":"2014"},{"key":"10.1016\/j.jamda.2021.12.043_bib42","series-title":"Antipsychotic Drugs Prescribed to Seniors at Alarming Rates\u00a0Province Finds Toronto","author":"Bruser","year":"2014"},{"key":"10.1016\/j.jamda.2021.12.043_bib43","series-title":"Drugged Seniors were Prescribed by Doctors: Minister","author":"Bruser","year":"2014"},{"key":"10.1016\/j.jamda.2021.12.043_bib44","author":"Matthews"},{"key":"10.1016\/j.jamda.2021.12.043_bib45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMp1704633","article-title":"Gabapentin and pregabalin for pain - is increased prescribing a cause for concern?","volume":"377","author":"Goodman","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.jamda.2021.12.043_bib46","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/alzrt201","article-title":"Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012","volume":"5","author":"Herrmann","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jamda.2021.12.043_bib47","first-page":"433","article-title":"Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: recommendations for family physicians","volume":"60","author":"Moore","year":"2014","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jamda.2021.12.043_bib48","doi-asserted-by":"crossref","first-page":"e2118441","DOI":"10.1001\/jamanetworkopen.2021.18441","article-title":"Comparison of medication prescribing before and after the COVID-19 pandemic among nursing home residents in Ontario, Canada","volume":"4","author":"Campitelli","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jamda.2021.12.043_bib49","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamainternmed.2018.6112","article-title":"Assessment of use of combined dextromethorphan and quinidine in patients with dementia or parkinson disease after US Food and Drug Administration approval for pseudobulbar affect","volume":"179","author":"Fralick","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2021.12.043_bib50","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3389\/fphar.2020.01168","article-title":"Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future progress","volume":"11","author":"Magierski","year":"2020","journal-title":"Front Pharmacol"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861022000196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861022000196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:29:17Z","timestamp":1761506957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861022000196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1525861022000196"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2021.12.043","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential Unintended Consequences of Antipsychotic Reduction in Ontario Nursing Homes","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2021.12.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}